In Europe, shortages of Novo Nordisk's Ozempic to persist into Q4: letter
Fierce Pharma
SEPTEMBER 3, 2024
The company and the European Medicines Agency warned European healthcare providers to continue limiting new patient prescriptions until the shortages let up.
Let's personalize your content